CL2019001260A1 - Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña - Google Patents

Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña

Info

Publication number
CL2019001260A1
CL2019001260A1 CL2019001260A CL2019001260A CL2019001260A1 CL 2019001260 A1 CL2019001260 A1 CL 2019001260A1 CL 2019001260 A CL2019001260 A CL 2019001260A CL 2019001260 A CL2019001260 A CL 2019001260A CL 2019001260 A1 CL2019001260 A1 CL 2019001260A1
Authority
CL
Chile
Prior art keywords
improved treatment
antimicrobial formulations
hoof infections
composition
infections
Prior art date
Application number
CL2019001260A
Other languages
English (en)
Inventor
Michael Kerr
Teresa Allen
Original Assignee
Provita Eurotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provita Eurotech Ltd filed Critical Provita Eurotech Ltd
Publication of CL2019001260A1 publication Critical patent/CL2019001260A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • A61K31/115Formaldehyde
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Abstract

Se proporciona una composición que comprende un material orgánico y al menos un primer tensioactivo que, después de la adición de una solución acuosa a la composición, puede formar un sistema bifásico, en el que el sistema bifásico es útil para el tratamiento o la prevención de infecciones de pezuña. También se proporciona un sistema bifásico útil para el tratamiento o la prevención de infecciones de pezuñas, en el que el sistema bifásico comprende la composición y una fase acuosa en la que la composición se dispersa como gotitas dentro de la fase acuosa.
CL2019001260A 2016-11-09 2019-05-07 Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña CL2019001260A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201618945 2016-11-09

Publications (1)

Publication Number Publication Date
CL2019001260A1 true CL2019001260A1 (es) 2019-09-13

Family

ID=60331657

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001260A CL2019001260A1 (es) 2016-11-09 2019-05-07 Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña

Country Status (11)

Country Link
US (2) US11344508B2 (es)
EP (1) EP3538072A1 (es)
JP (1) JP7058648B2 (es)
CN (1) CN110225746A (es)
BR (1) BR112019009463A2 (es)
CA (1) CA3043287A1 (es)
CL (1) CL2019001260A1 (es)
GB (1) GB2571235B (es)
MX (1) MX2019005383A (es)
WO (1) WO2018087554A1 (es)
ZA (1) ZA201902956B (es)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604283A (en) 1984-04-24 1986-08-05 Gresham Anne L Hoof conditioner and dressing and methods of use
US5891472A (en) 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US6028104A (en) * 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
NL1008795C2 (nl) * 1998-04-02 1999-10-05 Rene Werenfridus Lodewijk Vroo Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling.
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
PL358278A1 (en) * 2000-03-13 2004-08-09 Basf Aktiengesellschaft Agrotechnical formulation
US6444707B1 (en) * 2000-08-22 2002-09-03 West Agro Topically applied hoof treatment composition and concentrate
US6663902B1 (en) 2000-09-19 2003-12-16 Ecolab Inc. Method and composition for the generation of chlorine dioxide using Iodo-Compounds, and methods of use
EP2061447A1 (en) * 2006-09-08 2009-05-27 DeLaval Holding AB Compositions for the treatment of hoof diseases
GB0720716D0 (en) 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US8703104B2 (en) 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
ES2719200T3 (es) * 2008-10-29 2019-07-09 Arbor Pharmaceuticals Llc Sistema conservante para formulaciones tópicas terapéuticas basadas en emulsión
US8389581B2 (en) 2008-11-28 2013-03-05 Agrochem, Inc. Compositions and methods for treating hoof diseases
US20140287064A1 (en) 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
PL2408428T3 (pl) 2009-03-16 2017-06-30 Visions Marketing Group, Inc. Kompozycja bakteriobójcza
ES2673331T3 (es) 2010-01-15 2018-06-21 Ecolab Inc. Método para producir una capa de reservorio para el tratamiento de las pezuñas, y capa de reservorio
WO2012024324A1 (en) 2010-08-16 2012-02-23 Delaval Holding Ab System and method for delivering germicidal agent to animal hoof
WO2014098759A1 (en) 2012-12-21 2014-06-26 Delaval Holding Ab Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
US9750245B2 (en) 2013-03-08 2017-09-05 Laboratoire M2 Topical use of an antimicrobial formulation

Also Published As

Publication number Publication date
GB2571235A (en) 2019-08-21
BR112019009463A2 (pt) 2019-07-30
US20200054577A1 (en) 2020-02-20
JP2019535711A (ja) 2019-12-12
EP3538072A1 (en) 2019-09-18
JP7058648B2 (ja) 2022-04-22
GB201908192D0 (en) 2019-07-24
RU2019114202A3 (es) 2021-01-13
ZA201902956B (en) 2022-12-21
US20220257530A1 (en) 2022-08-18
CA3043287A1 (en) 2018-05-17
RU2019114202A (ru) 2020-12-10
WO2018087554A1 (en) 2018-05-17
GB2571235B (en) 2021-05-19
CN110225746A (zh) 2019-09-10
MX2019005383A (es) 2019-09-04
US11344508B2 (en) 2022-05-31

Similar Documents

Publication Publication Date Title
CL2018001762A1 (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas. (divisional solicitud 201402087).
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CO2019000846A2 (es) Concentrados de recubrimiento no tóxicos para usos agrícolas
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
CO2017010065A2 (es) Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina
CO2017008584A2 (es) Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
DOP2016000253A (es) Nuevos compuestos
PE20160052A1 (es) Composicion farmaceutica de clorhidrato de s-cetamina
CL2019003025A1 (es) Concentrados espumantes agrícolas que contienen una amida lineal. (divisional solicitud 201603221)
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
ECSP19036192A (es) Composición para el tratamiento y/o prevención de la enfermedad fúngica sigatoka negra en los cultivos de banana
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2016003258A1 (es) Composiciones parasiticidas que comprenden derivados de indol, métodos y usos de las mismas.
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
BR112018074905A2 (pt) composição para tratamento de planta
CL2017001454A1 (es) Métodos para preparar composiciones que contienen alcaloides y usos de las mismas
CR20160432A (es) Inhibidores de las vías de señalización de wnt
BR112018067918A2 (pt) formulações livres de solvente de substâncias ativas com baixo ponto de fusão
UY36196A (es) Compuestos para usar en el tratamiento antihelmíntico
AR109407A1 (es) Compuesto de 1-acetil-3-fenilurea y su uso
CL2020000551A1 (es) Formulación de uso tópico para el control y la prevención de parásitos en animales.